Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Sensors (Basel, Switzerland)
|
February 21, 2012
Biosensors for brain trauma and dual laser doppler flowmetry: enoxaparin simultaneously reduces stroke-induced dopamine and blood flow while enhancing serotonin and blood flow in motor neurons of brain, in vivo
Patricia A Broderick, Edwin H Kolodny
Pharmaceuticals (Basel, Switzerland)
|
October 8, 2016
Real Time Imaging of Biomarkers in the Parkinson's Brain Using Mini-Implantable Biosensors. II. Pharmaceutical Therapy with Bromocriptine
Patricia A Broderick, Edwin H Kolodny
Topics in Magnetic Resonance Imaging : TMRI
|
April 7, 2007
Leukodystrophies: clinical and genetic aspects
Gilles Lyon, Aviva Fattal-Valevski, Edwin H Kolodny
Clinical Therapeutics
|
October 4, 2005
An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment
Gregory M Pastores, Natalie L Barnett, Edwin H Kolodny
Headache
|
February 28, 2009
Acute confusional migraine may be a presenting feature of CADASIL
Swati Sathe, Edgar DePeralta, Gregory Pastores, et al.
Molecular Genetics and Metabolism
|
August 12, 2011
The enigma of the E326K mutation in acid β-glucocerebrosidase
Mia Horowitz, Metsada Pasmanik-Chor, Idit Ron, et al.
Muscle & Nerve
|
July 22, 2008
Late-onset Tay-Sachs disease: the spectrum of peripheral neuropathy in 30 affected patients
Barbara E Shapiro, Eric L Logigian, Edwin H Kolodny, et al.
Radiology
|
June 3, 2015
Skeletal Muscle in Healthy Subjects versus Those with GNE-Related Myopathy: Evaluation with Shear-Wave US--A Pilot Study
Elizabeth L Carpenter, Heather A Lau, Edwin H Kolodny, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 7, 2009
Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment
Barbara E Shapiro, Gregory M Pastores, John Gianutsos, et al.
Journal of Neurology
|
May 28, 2004
Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease
Max Josef Hilz, Edwin H Kolodny, Miroslaw Brys, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Sensors (Basel, Switzerland)
|
February 21, 2012
Biosensors for brain trauma and dual laser doppler flowmetry: enoxaparin simultaneously reduces stroke-induced dopamine and blood flow while enhancing serotonin and blood flow in motor neurons of brain, in vivo
Patricia A Broderick, Edwin H Kolodny
Pharmaceuticals (Basel, Switzerland)
|
October 8, 2016
Real Time Imaging of Biomarkers in the Parkinson's Brain Using Mini-Implantable Biosensors. II. Pharmaceutical Therapy with Bromocriptine
Patricia A Broderick, Edwin H Kolodny
Topics in Magnetic Resonance Imaging : TMRI
|
April 7, 2007
Leukodystrophies: clinical and genetic aspects
Gilles Lyon, Aviva Fattal-Valevski, Edwin H Kolodny
Clinical Therapeutics
|
October 4, 2005
An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment
Gregory M Pastores, Natalie L Barnett, Edwin H Kolodny
Headache
|
February 28, 2009
Acute confusional migraine may be a presenting feature of CADASIL
Swati Sathe, Edgar DePeralta, Gregory Pastores, et al.
Molecular Genetics and Metabolism
|
August 12, 2011
The enigma of the E326K mutation in acid β-glucocerebrosidase
Mia Horowitz, Metsada Pasmanik-Chor, Idit Ron, et al.
Muscle & Nerve
|
July 22, 2008
Late-onset Tay-Sachs disease: the spectrum of peripheral neuropathy in 30 affected patients
Barbara E Shapiro, Eric L Logigian, Edwin H Kolodny, et al.
Radiology
|
June 3, 2015
Skeletal Muscle in Healthy Subjects versus Those with GNE-Related Myopathy: Evaluation with Shear-Wave US--A Pilot Study
Elizabeth L Carpenter, Heather A Lau, Edwin H Kolodny, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
April 7, 2009
Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment
Barbara E Shapiro, Gregory M Pastores, John Gianutsos, et al.
Journal of Neurology
|
May 28, 2004
Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease
Max Josef Hilz, Edwin H Kolodny, Miroslaw Brys, et al.
Page
of 4